查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1541001

2024-2032 年腸道疾病檢測市場報告（按產品類型、技術、疾病類型、最終用戶和地區分類）

Enteric Disease Testing Market Report by Product Type, Technique, Disease Type, End User, and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 143 Pages | 商品交期: 2-3個工作天內

價格

IMARC Group年，全球腸道疾病檢測市場規模達42億美元。胃腸道感染發病率的上升、對早期檢測的認知不斷提高、診斷技術的進步、對快速準確檢測方法的需求不斷成長以及全球對食品和水安全標準的日益關注是推動市場成長的一些因素。

腸道疾病檢測市場分析：

主要市場驅動力：全球胃腸道感染盛行率不斷上升是市場的主要驅動力。衛生條件差、水污染和食源性病原體等因素導致腸道疾病發生率不斷上升。診斷技術的重大進步提供快速、準確的結果，進一步推動市場成長。

主要市場趨勢：分子診斷的廣泛採用代表了市場的主要趨勢。聚合酶鏈反應 (PCR) 和新一代定序 (NGS) 等技術因其高靈敏度、特異性和快速週轉時間而越來越受歡迎。這些先進的診斷方法能夠檢測多種病原體，有助於更準確、更全面的檢測。

地理趨勢：亞太地區是腸道疾病檢測市場成長最大的地區。由於衛生條件差、醫療保健意識增強、政府疾病控制措施以及診斷技術的進步，胃腸道感染的高發病率正在推動該地區的市場成長。

競爭格局：腸道疾病檢測行業的一些主要市場參與者包括 Abbott Laboratories、BD（Becton、Dickinson and Company）、Bio-Rad Laboratories Inc.、Biomerica Inc.、Biomerieux SA、Cepheid Inc.（Danaher Corporation）、 Corisanaher Corporation）、 Coris BioConcept、DiaSorin、Meridian Bioscience Inc. 和Quest Diagnostics 等。

挑戰與機會：市場面臨各種挑戰，包括偏遠和低收入地區先進診斷設施的使用有限，阻礙了及時的疾病檢測。然而，市場也面臨一些機遇，例如分子診斷和即時檢測的進步，可以提供快速、準確的結果。

腸道疾病檢測市場趨勢：

胃腸道感染發生率上升

由於衛生條件差、食物和水污染以及人口密度高，腸道疾病日益流行，特別是在發展中地區，正在推動對有效診斷檢測的需求。根據《印度時報》2024 年發表的一篇文章稱，由於水源污染和衛生條件差，班加羅爾的胃腸道感染病例增加。兒童有因腹瀉而脫水的風險，強調 ORS 的重要性並在感染期間避免牛奶。據世界衛生組織稱，全世界約有 150 萬人死於腹瀉。生活在發展中國家的 5 歲以下兒童尤其容易因營養不良而受到腹瀉和嘔吐等疾病的影響，甚至死亡。這進一步顯著提升了腸道疾病檢測市場價值。

不斷成長的政府措施和法規

新興的政府和衛生組織正在實施嚴格的食品和水安全標準，並投資公共衛生基礎設施。這進一步增加了對定期和可靠的腸道疾病檢測的需求，以防止疫情爆發並確保公共安全，這進一步促進了市場的成長。例如，2024 年 4 月，印度食品安全和標準局 (FSSAI) 與德里食品安全部門合作，針對國家首都的主要市場啟動了一項廣泛的意識和宣傳計劃。同樣，莫迪政府的一項關鍵計劃「國家衛生使命」（NHM）專注於改善醫療基礎設施、提供基本藥物和診斷以及加強基層人力資源能力。這些措施旨在減少患者在當地以外尋求昂貴治療的需要，這進一步推動了未來幾年腸道疾病檢測市場的預測。

診斷技術的重大進步

包括聚合酶鍊式反應（PCR）和下一代定序（NGS）在內的分子診斷領域不斷創新，可提供快速、準確和全面的腸道病原體檢測，從而推動了市場成長。例如，2023 年 8 月，ArcticZymes Technologies (AZT) 宣布推出新產品 AZtaq(TM) DNA 聚合酶。 AZtaq(TM) 是一種高品質熱穩定性 DNA 聚合酶，適用於聚合酶鍊式反應 (PCR) 應用。 AZtaq(TM) 的推出是公司分子工具產品組合的自然擴展。作為 PCR 中的必需酶，熱穩定性 DNA 聚合酶發揮關鍵作用，並在分子診斷和研究中實現了許多應用。這進一步推動了全球腸道疾病檢測市場的收入。

腸道疾病檢測市場區隔：

IMARC Group提供了每個細分市場的主要趨勢分析，以及 2024-2032 年全球、區域和國家層面的預測。我們的報告根據產品類型、技術、疾病類型和最終用戶對市場進行了分類。

按產品類型分類：

試劑及耗材

裝置

該報告根據產品類型對市場進行了詳細的細分和分析。這包括試劑和消耗品以及設備。

市場對試劑和耗材的需求是由對準確、高效的診斷過程的需求所驅動的。頻繁檢測胃腸道病原體需要持續供應高品質的試劑和耗材。此外，傳染病病率的上升，加上分子和快速檢測方法的進步，需要使用專門的耗材。政府資金的增加和醫療保健基礎設施的發展進一步增加了對這些基本測試組件的需求。

自動PCR系統和下一代定序平台等診斷機械的技術進步進一步推動了腸道疾病檢測市場報告中對設備的需求。對高通量、可靠且精確的診斷工具的需求推動了先進設備的採用。擴大醫療保健基礎設施（特別是在新興市場）以及增加對實驗室現代化的投資也有助於不斷成長的需求。加強的疾病監測計畫和公共衛生措施進一步刺激了診斷設備市場。

依技術分解：

分子診斷

免疫診斷

分子診斷佔產業最大佔有率

報告還提供了基於該技術的詳細市場細分和分析。這包括分子診斷和免疫診斷。報告稱，分子診斷佔據了最大的腸道疾病檢測市場。

市場對分子診斷技術的需求是由其高精度、靈敏度和快速週轉時間所推動的。 PCR 和新一代定序等技術可以精確識別多種病原體，進而改善疾病管理和疫情控制。例如，2023 年 11 月，羅氏宣布推出 LightCycler(R) PRO 系統，該系統基於先前的 LightCycler(R) 系統經過驗證的黃金標準技術。這個新系統提高了性能和可用性的標準，同時縮小了轉化研究和體外診斷之間的差距。 LightCycler PRO 系統進一步補充了羅氏的分子 PCR 檢測產品組合，其中包括為各種醫療保健專業人員提供的解決方案 - 從進行研究的人員到對患者進行癌症、傳染病和其他公共衛生挑戰測試的人員。這進一步推動了全球腸道疾病檢測的需求。

按疾病類型細分：

細菌性腸道疾病

艱難梭菌

彎曲菌病

霍亂

大腸桿菌

幽門螺旋桿菌

沙門氏菌病

志賀菌症

病毒性腸疾病

輪狀病毒

諾羅病毒

其他

寄生蟲性腸道疾病

阿米巴病

隱孢子蟲病

賈第鞭毛蟲病

細菌性腸道疾病佔業界最大佔有率

該報告根據疾病類型對市場進行了詳細的細分和分析。這包括細菌性腸道疾病（艱難梭菌、彎曲桿菌病、霍亂、大腸桿菌、幽門螺旋桿菌、沙門氏菌病和志賀氏菌病）、病毒性腸道疾病（輪狀病毒、諾羅病毒等）和寄生蟲性腸道疾病（阿米巴病、隱孢子蟲病和賈第蟲病）。報告稱，細菌性腸道疾病佔最大的市場佔有率。

艱難梭菌、大腸桿菌和沙門氏菌等感染的高流行推動了對細菌類型腸道疾病檢測的需求，這些感染構成了重大的公共衛生風險。快速、準確的診斷對於有效治療、疫情管理和感染控制至關重要。幽門螺旋桿菌與嚴重胃腸道疾病的關聯也刺激了檢測需求。食源性和水源性疫情的增加、嚴格的食品安全法規以及對有效醫療干預措施的需求進一步推動了細菌性腸道疾病檢測市場的發展。

按最終用戶分類：

醫院診斷實驗室

獨立診斷實驗室

學術及研究機構

其他

報告還提供了基於最終用戶的詳細市場細分和分析。這包括醫院診斷實驗室、獨立診斷實驗室、學術和研究機構等。

在醫院診斷實驗室中，對腸道疾病檢測的需求是由於需要及時、準確的診斷來確保有效的患者管理和治療。大量患者和診斷胃腸道感染的關鍵性質需要可靠和有效的測試方案。

獨立診斷實驗室因其專業服務和提供快速、大容量檢測的能力而看到了需求。它們在常規篩檢、疫情管理和提供先進的診斷技術、滿足醫療保健提供者和患者的需求方面發揮著至關重要的作用。這進一步創造了積極的腸道疾病檢測市場前景。

在學術和研究機構中，需求是由對腸道病原體研究、開發創新診斷方法和進行流行病學研究的關注所驅動的。傳染病研究資金和補助金的增加增強了對全面和精確檢測能力的需求，支持科學進步和公共衛生措施。

按地區分類：

北美洲

美國

加拿大

亞太地區

中國

日本

印度

韓國

澳洲

印尼

其他

歐洲

德國

法國

英國

義大利

西班牙

俄羅斯

其他

拉丁美洲

巴西

墨西哥

其他

中東和非洲

亞太地區引領市場，佔據最大腸道疾病檢測市場佔有率

該報告還對所有主要區域市場進行了全面分析，其中包括北美（美國和加拿大）；歐洲（德國、法國、英國、義大利、西班牙、俄羅斯等）；亞太地區（中國、日本、印度、韓國、澳洲、印尼等）；拉丁美洲（巴西、墨西哥等）；以及中東和非洲。報告稱，亞太地區是腸道疾病檢測的最大市場。

由於環境衛生和衛生條件差，胃腸道感染的發生率不斷上升，推動了亞太地區腸道疾病檢測市場的發展。全球腸道多中心研究 (GEMS) 關於發展中國家兒童腹瀉負擔和病因的最新資料顯示，輪狀病毒、隱孢子蟲屬、產腸毒素大腸桿菌 (ETEC) 和志賀氏菌屬。是腹瀉病和死亡的主要原因。此外，諾羅病毒感染是食源性疾病爆發的主要原因，與約 20% 的腹瀉病例有關，兒童和成人的盛行率相似。因此，人們對健康問題的認知不斷增強、政府加強疾病控制措施以及醫療保健基礎設施的改善也刺激了需求。診斷技術的進步以及食品和水源性疾病盛行率的上升進一步推動了市場的成長。快速的城市化和不斷擴大的中產階級人口基數，以及更多的醫療保健機會，正在促進市場的成長。

競爭格局：

市場研究報告也對市場競爭格局進行了全面分析。也提供了所有主要公司的詳細資料。腸道疾病檢測產業的一些主要市場參與者包括 Abbott Laboratories、BD（Becton、Dickinson and Company）、Bio-Rad Laboratories Inc.、Biomerica Inc.、Biomerieux SA、Cepheid Inc.（Danaher Corporation）、Coris BioConcept、 DiaSorin 、Meridian Bioscience Inc. 和Quest Diagnostics。

（請注意，這只是關鍵參與者的部分列表，報告中提供了完整列表。）

腸道疾病檢測市場的競爭格局非常激烈，主要參與者包括 Abbott Laboratories、Thermo Fisher Scientific、Bio-Rad Laboratories 和 Becton, Dickinson and Company。這些企業專注於開發先進的診斷技術，包括分子診斷和快速檢測試劑盒，以提高檢測的準確性和速度。例如，2023 年 7 月，Thermo Fisher Scientific 推出了 Diomni Enterprise Software，幫助簡化常規診斷測試，實現標準化並加快獲得結果的速度，以應對容易出錯的手動分子測試工作流程的挑戰。透過在一個介面內連接工作流程步驟，Diomni Enterprise 可以提高實驗室動態回應當今快速變化的測試環境的能力。

腸道疾病檢測市場新聞：

2023 年 3 月，Biomerica, Inc. 宣布推出 InFoods(R) IBS 測試。該測試在 CLIA 認證和 CAP 認可的高複雜性實驗室設施中進行，並作為實驗室開發的測試 (LDT) 提供。該公司進一步宣布，以 LDT 形式提供 InFoods IBS 產品所需的所有驗證測試均已完成。第一批患者樣本已經處理完畢。

2022 年10 月，科學領域的全球領導者賽默飛世爾科技(Thermo Fisher Scientific) 宣布推出TaqPath 腸道細菌選擇檢測試劑盒，這是一款經過CE-IVD 標記的檢測試劑盒，旨在檢測常見胃腸道(GI) 細菌，幫助臨床醫生識別腸道細菌。該面板於 2022 年 5 月通過了 IVDD 驗證並註冊。

本報告回答的關鍵問題：

  • 迄今為止，全球腸道疾病檢測市場表現如何，未來幾年將如何表現？
  • 全球腸道疾病檢測市場的促進因素、限制因素和機會是什麼？
  • 每個促進因素、限制因素和機會對全球腸道疾病檢測市場有何影響？
  • 主要區域市場有哪些？
  • 哪些國家代表了最具吸引力的腸道疾病檢測市場？
  • 依產品類型分類的市場是怎麼樣的？
  • 腸道疾病檢測市場最具吸引力的產品類型是什麼？
  • 基於技術的市場區隔是什麼？
  • 腸道疾病檢測市場中哪種技術最具吸引力？
  • 根據疾病類型的市場分類是怎樣的？
  • 腸道疾病檢測市場中哪種疾病類型最具吸引力？
  • 基於最終用戶的市場區隔是什麼？
  • 腸道疾病檢測市場中哪一個對最終用戶最具吸引力？
  • 市場競爭結構如何？
  • 全球腸道疾病檢測市場的主要參與者/公司有哪些？

本報告回答的關鍵問題：

  • 迄今為止，全球腸道疾病檢測市場表現如何，未來幾年將如何表現？
  • 全球腸道疾病檢測市場的促進因素、限制因素和機會是什麼？
  • 每個促進因素、限制因素和機會對全球腸道疾病檢測市場有何影響？
  • 主要區域市場有哪些？
  • 哪些國家代表了最具吸引力的腸道疾病檢測市場？
  • 依產品類型分類的市場是怎麼樣的？
  • 腸道疾病檢測市場最具吸引力的產品類型是什麼？
  • 基於技術的市場區隔是什麼？
  • 腸道疾病檢測市場中哪種技術最具吸引力？
  • 根據疾病類型的市場分類是怎樣的？
  • 腸道疾病檢測市場最有吸引力的疾病類型是什麼？
  • 基於最終用戶的市場區隔是什麼？
  • 腸道疾病檢測市場中哪一個對最終用戶最具吸引力？
  • 市場競爭結構如何？
  • 全球腸道疾病檢測市場的主要參與者/公司有哪些？

目錄

第1章：前言

第 2 章：範圍與方法

  • 研究目的
  • 利害關係人
  • 數據來源
    • 主要來源
    • 二手資料
  • 市場預測
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第 3 章：執行摘要

第 4 章：簡介

  • 概述
  • 主要行業趨勢

第 5 章：全球腸道疾病檢測市場

  • 市場概況
  • 市場表現
  • COVID-19 的影響
  • 市場預測

第 6 章：市場區隔：依產品類型

  • 試劑及耗材
    • 市場趨勢
    • 市場預測
  • 裝置
    • 市場趨勢
    • 市場預測

第 7 章：市場區隔：依技術

  • 分子診斷
    • 市場趨勢
    • 市場預測
  • 免疫診斷
    • 市場趨勢
    • 市場預測

第 8 章：市場區隔：依疾病類型

  • 細菌性腸道疾病
    • 市場趨勢
    • 主要類型
      • 艱難梭菌
      • 彎曲菌病
      • 霍亂
      • 大腸桿菌
      • 幽門螺旋桿菌
      • 沙門氏菌病
      • 志賀菌症
    • 市場預測
  • 病毒性腸疾病
    • 市場趨勢
    • 主要類型
      • 輪狀病毒
      • 諾羅病毒
      • 其他
    • 市場預測
  • 寄生蟲性腸道疾病
    • 市場趨勢
    • 主要類型
      • 阿米巴病
      • 隱孢子蟲病
      • 賈第鞭毛蟲病
    • 市場預測

第 9 章：市場區隔：按最終用戶

  • 醫院診斷實驗室
    • 市場趨勢
    • 市場預測
  • 獨立診斷實驗室
    • 市場趨勢
    • 市場預測
  • 學術及研究機構
    • 市場趨勢
    • 市場預測
  • 其他
    • 市場趨勢
    • 市場預測

第 10 章：市場區隔：按地區

  • 北美洲
    • 美國
    • 加拿大
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲
    • 市場趨勢
    • 市場細分：按國家/地區
    • 市場預測

第 11 章：SWOT 分析

  • 概述
  • 優勢
  • 弱點
  • 機會
  • 威脅

第 12 章：價值鏈分析

第 13 章：波特五力分析

  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第 14 章：價格分析

第15章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • Abbott Laboratories
    • BD (Becton, Dickinson and Company)
    • Bio-Rad Laboratories Inc.
    • Biomerica Inc.
    • Biomerieux SA
    • Cepheid Inc. (Danaher Corporation)
    • Coris BioConcept
    • DiaSorin
    • Meridian Bioscience Inc.
    • Quest Diagnostics
Product Code: SR112024A2544

The global enteric disease testing market size reached US$ 4.2 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 5.5 Billion by 2032, exhibiting a growth rate (CAGR) of 3.1% during 2024-2032. The rising incidences of gastrointestinal infections, increasing awareness about the early detection, advancements in diagnostic technologies, the growing demand for rapid and accurate testing methods, and rising global focus on food and water safety standards are some of the factors propelling the growth of the market.

Enteric Disease Testing Market Analysis:

Major Market Drivers: The rising prevalence of gastrointestinal infections across the globe represents the major driver of the market. Factors including poor sanitation, contaminated water, and foodborne pathogens contribute to the increasing incidence of enteric diseases. Significant advancements in diagnostic technologies offering rapid and accurate results further driving the market growth.

Key Market Trends: The widespread adoption of molecular diagnostics represents the key trends in the market. Techniques including polymerase chain reaction (PCR) and next-generation sequencing (NGS) are gaining popularity due to their high sensitivity, specificity, and rapid turnaround time. These advanced diagnostic methods enable the detection of a wide range of pathogens, contributing to more accurate and comprehensive testing.

Geographical Trends: Asia Pacific accounts for the largest region in the enteric disease testing market growth. The high incidence of gastrointestinal infections is driving the market growth across the region due to poor sanitation, increasing healthcare awareness, government initiatives for disease control, and advancements in diagnostic technologies.

Competitive Landscape: Some of the major market players in the enteric disease testing industry include Abbott Laboratories, BD (Becton, Dickinson and Company), Bio-Rad Laboratories Inc., Biomerica Inc., Biomerieux SA, Cepheid Inc. (Danaher Corporation), Coris BioConcept, DiaSorin, Meridian Bioscience Inc. and Quest Diagnostics, among many others.

Challenges and Opportunities: The market faces various challenges including limited access to advanced diagnostic facilities in remote and low-income regions, which hampers timely disease detection. However, the market also faces several opportunities such as advancements in molecular diagnostics and point-of-care testing which offer rapid and accurate results.

Enteric Disease Testing Market Trends:

Rising Incidence of Gastrointestinal Infections

The growing prevalence of enteric diseases due to poor sanitation, contaminated food and water, and high population density, especially in developing regions, is driving the demand for effective diagnostic testing. According to an article published by the Times of India in 2024, Bengaluru witnesses a rise in gastrointestinal infections attributed to contaminated water sources and poor sanitation. Children are at risk of dehydration due to diarrhea, emphasizing the importance of ORS and avoiding milk during infections. According to the WHO, approximately 1.5 million people worldwide die of diarrheal disease alone. Children under the age of 5 living in developing countries are particularly affected by conditions such as diarrhea and vomiting through malnutrition and death. This is further boosting the enteric disease testing market value significantly.

Growing Government Initiatives and Regulations

The rising government and health organizations are implementing strict food and water safety standards and investing in public health infrastructure. This further increases the need for regular and reliable enteric disease testing to prevent outbreaks and ensure public safety which is further contributing to the growth of the market. For instance, in April 2024, The Food Safety and Standards Authority of India (FSSAI) launched an extensive awareness and sensitization program targeting major markets in the national capital, in collaboration with the Food Safety Department, Delhi. Similarly, the National Health Mission (NHM), a key program under the Modi government, focuses on improving healthcare infrastructure, providing essential drugs and diagnostics, and strengthening human resource capabilities at the grassroots level. These initiatives are aimed at reducing the need for patients to seek expensive treatments outside their localities which is further boosting the enteric disease testing market forecast over the coming years.

Significant Advancements in Diagnostic Technologies

The increasing innovation in molecular diagnostics including polymerase chain reaction (PCR) and next-generation sequencing (NGS), provide rapid, accurate, and comprehensive detection of enteric pathogens, which is boosting the market growth. For instance, in August 2023, ArcticZymes Technologies (AZT) announced the launch of its new product, AZtaq(TM) DNA Polymerase. AZtaq(TM) is a high-quality thermostable DNA polymerase suitable for use in polymerase chain reaction (PCR) applications. Launched the AZtaq(TM) is a natural expansion of the Company's molecular tools portfolio. Being an essential enzyme in PCR, the thermostable DNA polymerase plays a pivotal role and enables numerous applications within molecular diagnostics and research. This is further driving the enteric disease testing market revenue across the globe.

Enteric Disease Testing Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the global, regional, and country levels for 2024-2032. Our report has categorized the market based on product type, technique, disease type, and end user.

Breakup by Product Type:

Reagents and Consumables

Equipment

The report has provided a detailed breakup and analysis of the market based on the product type. This includes reagents and consumables, and equipment.

The demand for reagents and consumables in the market is driven by the need for accurate and efficient diagnostic processes. Frequent testing for gastrointestinal pathogens requires a constant supply of high-quality reagents and consumables. Additionally, the rise in infectious disease prevalence, coupled with advancements in molecular and rapid testing methods, necessitates the use of specialized consumables. Increased government funding and healthcare infrastructure development further boost demand for these essential testing components.

Technological advancements in diagnostic machinery, such as automated PCR systems and next-generation sequencing platforms are further driving the demand for equipment in the enteric disease testing market report. The need for high-throughput, reliable, and precise diagnostic tools drive the adoption of advanced equipment. Expanding healthcare infrastructure, particularly in emerging markets, and increased investment in laboratory modernization also contribute to the growing demand. Enhanced disease surveillance programs and public health initiatives further stimulate the market for diagnostic equipment.

Breakup by Technique:

Molecular Diagnostics

Immunodiagnostics

Molecular diagnostics holds the largest share of the industry

A detailed breakup and analysis of the market based on the technique have also been provided in the report. This includes molecular diagnostics and immunodiagnostics. According to the report, molecular diagnostics accounted for the largest enteric disease testing market share.

The demand for molecular diagnostics techniques in the market is driven by their high accuracy, sensitivity, and rapid turnaround times. These techniques, such as PCR and next-generation sequencing, enable precise identification of a wide range of pathogens, improving disease management and outbreak control. For instance, in November 2023, Roche announced the launch of the LightCycler(R) PRO System based on the proven gold standard technology of the LightCycler(R) Systems that came before it. This new system raises the bar for performance and usability while bridging the gap between translational research and in vitro diagnostics. The LightCycler PRO System further complements Roche's molecular PCR testing portfolio, which includes solutions for a variety of healthcare professionals - from those performing research to those testing patients for cancer, infectious diseases, and other public health challenges. This is further driving the enteric disease testing demand across the globe.

Breakup by Disease Type:

Bacterial Enteric Disease

C. Difficile

Campylobacteriosis

Cholera

E. Coli

H. Pylori

Salmonellosis

Shigellosis

Viral Enteric Disease

Rotavirus

Norovirus

Others

Parasitic Enteric Disease

Amebiasis

Cryptosporidiosis

Giardiasis

Bacterial enteric disease holds the largest share of the industry

The report has provided a detailed breakup and analysis of the market based on the disease type. This includes Bacterial Enteric Disease (C. Difficile, Campylobacteriosis, Cholera, E. Coli, H. Pylori, Salmonellosis, and Shigellosis), Viral Enteric Disease (Rotavirus, Norovirus, and Others), and Parasitic Enteric Disease (Amebiasis, Cryptosporidiosis, and Giardiasis). According to the report, Bacterial Enteric Disease accounted for the largest market share.

The demand for enteric disease testing in bacterial types is driven by the high prevalence of infections like C. difficile, E. coli, and Salmonellosis, which pose significant public health risks. Rapid, accurate diagnostics are crucial for effective treatment, outbreak management, and infection control. The association of H. pylori with severe gastrointestinal conditions also fuels testing demand. Increasing foodborne and waterborne outbreaks, stringent food safety regulations, and the need for efficient healthcare interventions further boost the market for bacterial enteric disease testing.

Breakup by End User:

Hospital Diagnostic Laboratories

Independent Diagnostic Laboratories

Academic and Research Institutes

Others

A detailed breakup and analysis of the market based on the end user have also been provided in the report. This includes hospital diagnostic laboratories, independent diagnostic laboratories, academic and research institutes, and others.

In hospital diagnostic laboratories, the demand for enteric disease testing is driven by the necessity for prompt and accurate diagnosis to ensure effective patient management and treatment. High patient volumes and the critical nature of diagnosing gastrointestinal infections necessitate reliable and efficient testing protocols.

Independent diagnostic laboratories see demand due to their specialized services and ability to provide rapid, high-volume testing. They play a crucial role in routine screening, outbreak management, and offering advanced diagnostic techniques, meeting the needs of both healthcare providers and patients. This is further creating a positive enteric disease testing market outlook.

In academic and research institutes, demand is driven by the focus on studying enteric pathogens, developing innovative diagnostic methods, and conducting epidemiological research. Increased funding and grants for infectious disease research enhance the need for comprehensive and precise testing capabilities, supporting scientific advancements and public health initiatives.

Breakup by Region:

North America

United States

Canada

Asia Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Asia Pacific leads the market, accounting for the largest enteric disease testing market share

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, Asia Pacific represents the largest market for enteric disease testing.

The market for enteric disease testing in Asia Pacific is driven by the increasing incidence rates of gastrointestinal infections due to poor sanitation and hygiene. Recent data from the Global Enteric Multicenter Study (GEMS) on the burden and etiology of diarrhea among children residing in developing countries showed that rotavirus, Cryptosporidium spp., enterotoxigenic Escherichia coli (ETEC), and Shigella spp. are the major causes of diarrheal diseases and death. Furthermore, norovirus infections are the principal cause of foodborne disease outbreaks and are associated with approximately 20% of diarrhea cases, with similar prevalence in both children and adults. Consequently, the growing awareness of health issues, increased government initiatives for disease control, and improvements in healthcare infrastructure also boost demand. Advancements in diagnostic technologies and the rising prevalence of food and waterborne diseases further propel the market growth. Rapid urbanization and the expanding middle class population base, with greater access to healthcare, are contributing to the market growth.

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the major market players in the enteric disease testing industry include Abbott Laboratories, BD (Becton, Dickinson and Company), Bio-Rad Laboratories Inc., Biomerica Inc., Biomerieux SA, Cepheid Inc. (Danaher Corporation), Coris BioConcept, DiaSorin, Meridian Bioscience Inc. and Quest Diagnostics.

(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)

The competitive landscape of the enteric disease testing market is highly competitive with key players such as Abbott Laboratories, Thermo Fisher Scientific, Bio-Rad Laboratories, and Becton, Dickinson and Company. These players focus on developing advanced diagnostic technologies, including molecular diagnostics and rapid testing kits, to enhance detection accuracy and speed. For instance, in July 2023, Thermo Fisher Scientific introduced Diomni Enterprise Software, helping streamline routine diagnostics testing for standardization and faster time-to-results to address challenges with error-prone, manual molecular testing workflows. By connecting workflow steps within one interface, Diomni Enterprise can increase a lab's ability to dynamically respond to today's rapidly changing testing environment.

Enteric Disease Testing Market News:

In March 2023, Biomerica, Inc. announced the launch of its InFoods(R) IBS test. The test is being performed in a CLIA-certified, and CAP-accredited high-complexity laboratory facility and offered as a laboratory-developed test (LDT). The Company further announced all validation testing necessary for the InFoods IBS product to be offered as an LDT has been completed. The first patient samples have been processed.

In October 2022, Thermo Fisher Scientific, the world leader in the field of science, announced the launch of the TaqPath Enteric Bacterial Select Panel, a CE-IVD marked panel designed to detect common gastrointestinal (GI) bacteria and help enable clinicians to identify the root cause of an infection and administer the most appropriate treatment to their patients more quickly. The panel was validated and registered under IVDD in May 2022.

Key Questions Answered in This Report:

  • How has the global enteric disease testing market performed so far, and how will it perform in the coming years?
  • What are the drivers, restraints, and opportunities in the global enteric disease testing market?
  • What is the impact of each driver, restraint, and opportunity on the global enteric disease testing market?
  • What are the key regional markets?
  • Which countries represent the most attractive enteric disease testing market?
  • What is the breakup of the market based on the product type?
  • Which is the most attractive product type in the enteric disease testing market?
  • What is the breakup of the market based on the technique?
  • Which is the most attractive technique in the enteric disease testing market?
  • What is the breakup of the market based on the disease type?
  • Which is the most attractive disease type in the enteric disease testing market?
  • What is the breakup of the market based on the end user?
  • Which is the most attractive end user in the enteric disease testing market?
  • What is the competitive structure of the market?
  • Who are the key players/companies in the global enteric disease testing market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Enteric Disease Testing Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product Type

  • 6.1 Reagents and Consumables
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Equipment
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Technique

  • 7.1 Molecular Diagnostics
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Immunodiagnostics
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by Disease Type

  • 8.1 Bacterial Enteric Disease
    • 8.1.1 Market Trends
    • 8.1.2 Major Types
      • 8.1.2.1 C. Difficile
      • 8.1.2.2 Campylobacteriosis
      • 8.1.2.3 Cholera
      • 8.1.2.4 E. Coli
      • 8.1.2.5 H. Pylori
      • 8.1.2.6 Salmonellosis
      • 8.1.2.7 Shigellosis
    • 8.1.3 Market Forecast
  • 8.2 Viral Enteric Disease
    • 8.2.1 Market Trends
    • 8.2.2 Major Types
      • 8.2.2.1 Rotavirus
      • 8.2.2.2 Norovirus
      • 8.2.2.3 Others
    • 8.2.3 Market Forecast
  • 8.3 Parasitic Enteric Disease
    • 8.3.1 Market Trends
    • 8.3.2 Major Types
      • 8.3.2.1 Amebiasis
      • 8.3.2.2 Cryptosporidiosis
      • 8.3.2.3 Giardiasis
    • 8.3.3 Market Forecast

9 Market Breakup by End User

  • 9.1 Hospital Diagnostic Laboratories
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Independent Diagnostic Laboratories
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Academic and Research Institutes
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Others
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Abbott Laboratories
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
      • 15.3.1.3 Financials
      • 15.3.1.4 SWOT Analysis
    • 15.3.2 BD (Becton, Dickinson and Company)
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
      • 15.3.2.3 Financials
      • 15.3.2.4 SWOT Analysis
    • 15.3.3 Bio-Rad Laboratories Inc.
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
      • 15.3.3.3 Financials
      • 15.3.3.4 SWOT Analysis
    • 15.3.4 Biomerica Inc.
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
      • 15.3.4.3 Financials
      • 15.3.4.4 SWOT Analysis
    • 15.3.5 Biomerieux SA
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
      • 15.3.5.3 Financials
      • 15.3.5.4 SWOT Analysis
    • 15.3.6 Cepheid Inc. (Danaher Corporation)
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
      • 15.3.6.3 SWOT Analysis
    • 15.3.7 Coris BioConcept
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
    • 15.3.8 DiaSorin
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 Financials
      • 15.3.8.4 SWOT Analysis
    • 15.3.9 Meridian Bioscience Inc.
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
      • 15.3.9.3 Financials
      • 15.3.9.4 SWOT Analysis
    • 15.3.10 Quest Diagnostics
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
      • 15.3.10.3 Financials
      • 15.3.10.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Enteric Disease Testing Market: Major Drivers and Challenges
  • Figure 2: Global: Enteric Disease Testing Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Enteric Disease Testing Market: Breakup by Product Type (in %), 2023
  • Figure 4: Global: Enteric Disease Testing Market: Breakup by Technique (in %), 2023
  • Figure 5: Global: Enteric Disease Testing Market: Breakup by Disease Type (in %), 2023
  • Figure 6: Global: Enteric Disease Testing Market: Breakup by End User (in %), 2023
  • Figure 7: Global: Enteric Disease Testing Market: Breakup by Region (in %), 2023
  • Figure 8: Global: Enteric Disease Testing Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 9: Global: Enteric Disease Testing (Reagents and Consumables) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 10: Global: Enteric Disease Testing (Reagents and Consumables) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 11: Global: Enteric Disease Testing (Equipment) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 12: Global: Enteric Disease Testing (Equipment) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 13: Global: Enteric Disease Testing (Molecular Diagnostics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 14: Global: Enteric Disease Testing (Molecular Diagnostics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 15: Global: Enteric Disease Testing (Immunodiagnostics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 16: Global: Enteric Disease Testing (Immunodiagnostics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 17: Global: Enteric Disease Testing (Bacterial Enteric Disease) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 18: Global: Enteric Disease Testing (Bacterial Enteric Disease) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 19: Global: Enteric Disease Testing (Viral Enteric Disease) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 20: Global: Enteric Disease Testing (Viral Enteric Disease) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 21: Global: Enteric Disease Testing (Parasitic Enteric Disease) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 22: Global: Enteric Disease Testing (Parasitic Enteric Disease) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 23: Global: Enteric Disease Testing (Hospital Diagnostic Laboratories) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 24: Global: Enteric Disease Testing (Hospital Diagnostic Laboratories) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 25: Global: Enteric Disease Testing (Independent Diagnostic Laboratories) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 26: Global: Enteric Disease Testing (Independent Diagnostic Laboratories) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 27: Global: Enteric Disease Testing (Academic and Research Institutes) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 28: Global: Enteric Disease Testing (Academic and Research Institutes) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 29: Global: Enteric Disease Testing (Other End Users) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 30: Global: Enteric Disease Testing (Other End Users) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 31: North America: Enteric Disease Testing Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 32: North America: Enteric Disease Testing Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 33: United States: Enteric Disease Testing Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 34: United States: Enteric Disease Testing Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 35: Canada: Enteric Disease Testing Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 36: Canada: Enteric Disease Testing Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 37: Asia Pacific: Enteric Disease Testing Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 38: Asia Pacific: Enteric Disease Testing Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 39: China: Enteric Disease Testing Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 40: China: Enteric Disease Testing Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 41: Japan: Enteric Disease Testing Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 42: Japan: Enteric Disease Testing Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 43: India: Enteric Disease Testing Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 44: India: Enteric Disease Testing Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 45: South Korea: Enteric Disease Testing Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 46: South Korea: Enteric Disease Testing Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 47: Australia: Enteric Disease Testing Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 48: Australia: Enteric Disease Testing Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 49: Indonesia: Enteric Disease Testing Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 50: Indonesia: Enteric Disease Testing Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 51: Others: Enteric Disease Testing Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 52: Others: Enteric Disease Testing Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 53: Europe: Enteric Disease Testing Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 54: Europe: Enteric Disease Testing Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 55: Germany: Enteric Disease Testing Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 56: Germany: Enteric Disease Testing Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 57: France: Enteric Disease Testing Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 58: France: Enteric Disease Testing Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 59: United Kingdom: Enteric Disease Testing Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 60: United Kingdom: Enteric Disease Testing Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 61: Italy: Enteric Disease Testing Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 62: Italy: Enteric Disease Testing Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 63: Spain: Enteric Disease Testing Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 64: Spain: Enteric Disease Testing Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 65: Russia: Enteric Disease Testing Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 66: Russia: Enteric Disease Testing Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 67: Others: Enteric Disease Testing Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 68: Others: Enteric Disease Testing Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 69: Latin America: Enteric Disease Testing Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 70: Latin America: Enteric Disease Testing Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 71: Brazil: Enteric Disease Testing Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 72: Brazil: Enteric Disease Testing Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 73: Mexico: Enteric Disease Testing Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 74: Mexico: Enteric Disease Testing Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 75: Others: Enteric Disease Testing Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 76: Others: Enteric Disease Testing Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 77: Middle East and Africa: Enteric Disease Testing Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 78: Middle East and Africa: Enteric Disease Testing Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 79: Global: Enteric Disease Testing Industry: SWOT Analysis
  • Figure 80: Global: Enteric Disease Testing Industry: Value Chain Analysis
  • Figure 81: Global: Enteric Disease Testing Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Enteric Disease Testing Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Enteric Disease Testing Market Forecast: Breakup by Product Type (in Million US$), 2024-2032
  • Table 3: Global: Enteric Disease Testing Market Forecast: Breakup by Technique (in Million US$), 2024-2032
  • Table 4: Global: Enteric Disease Testing Market Forecast: Breakup by Disease Type (in Million US$), 2024-2032
  • Table 5: Global: Enteric Disease Testing Market Forecast: Breakup by End User (in Million US$), 2024-2032
  • Table 6: Global: Enteric Disease Testing Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 7: Global: Enteric Disease Testing Market Structure
  • Table 8: Global: Enteric Disease Testing Market: Key Players